Boehringer Ingelheim, Eli Lilly sales and marketing update

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) said in two separate early benefit assessments that added benefit for Jardiance empagliflozin as monotherapy from Boehringer and ...